schliessen

Filtern

 

Bibliotheken

Diverse effects of interleukin-22 on pancreatic diseases

Interleukin-22 (IL-22) is involved in the development of lymphocytes and serves as a rapid and early source of the effector cytokines that are released in response to pathogen-induced changes in the microenvironment. Recent research has implicated IL-22 as a potential contributing factor to the spec... Full description

Journal Title: Pancreatology April 2018, Vol.18(3), pp.231-237
Main Author: Xuan, Xiuyun
Other Authors: Tian, Zhiqiang , Zhang, Mengjie , Zhou, Jian , Gao, Weiwu , Zhang, Yi , Zhang, Yue , Lei, Bo , Ni, Bing , Wu, Yuzhang , Fan, Weiping
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 1424-3903 ; E-ISSN: 1424-3911 ; DOI: 10.1016/j.pan.2018.02.014
Link: http://dx.doi.org/10.1016/j.pan.2018.02.014
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: elsevier_sdoi_10_1016_j_pan_2018_02_014
title: Diverse effects of interleukin-22 on pancreatic diseases
format: Article
creator:
  • Xuan, Xiuyun
  • Tian, Zhiqiang
  • Zhang, Mengjie
  • Zhou, Jian
  • Gao, Weiwu
  • Zhang, Yi
  • Zhang, Yue
  • Lei, Bo
  • Ni, Bing
  • Wu, Yuzhang
  • Fan, Weiping
subjects:
  • Pancreatic Cancer
  • Interleukin-22
  • Cytokine
  • Signal Transducer
  • Pancreatic Cancer
  • Interleukin-22
  • Cytokine
  • Signal Transducer
  • Anatomy & Physiology
ispartof: Pancreatology, April 2018, Vol.18(3), pp.231-237
description: Interleukin-22 (IL-22) is involved in the development of lymphocytes and serves as a rapid and early source of the effector cytokines that are released in response to pathogen-induced changes in the microenvironment. Recent research has implicated IL-22 as a potential contributing factor to the spectrum of inflammation-related pancreatic diseases, particularly pancreatitis, fibrosis, carcinoma and diabetes. In this review, we summarize the current knowledge on the roles of IL-22 in the various pancreatic pathogenesis, providing insights into the underlying cellular and signaling mechanisms that will help guide future research into promising interventional targets with therapeutic potential.
language: eng
source:
identifier: ISSN: 1424-3903 ; E-ISSN: 1424-3911 ; DOI: 10.1016/j.pan.2018.02.014
fulltext: fulltext
issn:
  • 1424-3903
  • 14243903
  • 1424-3911
  • 14243911
url: Link


@attributes
ID1682908650
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordiddoi_10_1016_j_pan_2018_02_014
sourceidelsevier_s
recordidTN_elsevier_sdoi_10_1016_j_pan_2018_02_014
sourcesystemPC
dbid
0--K
1.FO
21P~
3457
4AAEDT
5AAKOC
6ACDAQ
7ADALY
8ADPAM
9AEVXI
10AFKWA
11AFTJW
12AFXIZ
13AGHFR
14AIKHN
15AITUG
16AJUYK
17ALXNB
18BELOY
19BNPGV
20FDB
21FGOYB
22GBLVA
23KOM
24OC.
25ON0
26R2-
27SEL
28SSH
29SSZ
30Z5R
pqid2019871094
galeid579106954
display
typearticle
titleDiverse effects of interleukin-22 on pancreatic diseases
creatorXuan, Xiuyun ; Tian, Zhiqiang ; Zhang, Mengjie ; Zhou, Jian ; Gao, Weiwu ; Zhang, Yi ; Zhang, Yue ; Lei, Bo ; Ni, Bing ; Wu, Yuzhang ; Fan, Weiping
ispartofPancreatology, April 2018, Vol.18(3), pp.231-237
identifier
subjectPancreatic Cancer ; Interleukin-22 ; Cytokine ; Signal Transducer ; Pancreatic Cancer ; Interleukin-22 ; Cytokine ; Signal Transducer ; Anatomy & Physiology
descriptionInterleukin-22 (IL-22) is involved in the development of lymphocytes and serves as a rapid and early source of the effector cytokines that are released in response to pathogen-induced changes in the microenvironment. Recent research has implicated IL-22 as a potential contributing factor to the spectrum of inflammation-related pancreatic diseases, particularly pancreatitis, fibrosis, carcinoma and diabetes. In this review, we summarize the current knowledge on the roles of IL-22 in the various pancreatic pathogenesis, providing insights into the underlying cellular and signaling mechanisms that will help guide future research into promising interventional targets with therapeutic potential.
languageeng
source
version7
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://dx.doi.org/10.1016/j.pan.2018.02.014$$EView_record_in_ScienceDirect_(Access_to_full_text_may_be_restricted)
search
creatorcontrib
0Xuan, Xiuyun
1Tian, Zhiqiang
2Zhang, Mengjie
3Zhou, Jian
4Gao, Weiwu
5Zhang, Yi
6Zhang, Yue
7Lei, Bo
8Ni, Bing
9Wu, Yuzhang
10Fan, Weiping
titleDiverse effects of interleukin-22 on pancreatic diseases
description

Interleukin-22 (IL-22) is involved in the development of lymphocytes and serves as a rapid and early source of the effector cytokines that are released in response to pathogen-induced changes in the microenvironment. Recent research has implicated IL-22 as a potential contributing factor to the spectrum of inflammation-related pancreatic diseases, particularly pancreatitis, fibrosis, carcinoma and diabetes. In this review, we summarize the current knowledge on the roles of IL-22 in the various pancreatic pathogenesis, providing insights into the underlying cellular and signaling mechanisms that will help guide future research into promising interventional targets with therapeutic potential.

subject
0Pancreatic Cancer
1Interleukin-22
2Cytokine
3Signal Transducer
4Anatomy & Physiology
general
0English
1Elsevier B.V
210.1016/j.pan.2018.02.014
3ScienceDirect (Elsevier)
4ScienceDirect Journals (Elsevier)
sourceidelsevier_s
recordidelsevier_sdoi_10_1016_j_pan_2018_02_014
issn
01424-3903
114243903
21424-3911
314243911
rsrctypearticle
creationdate2018
addtitlePancreatology
searchscope
0elsevier_full
1elsevier2
scope
0elsevier_full
1elsevier2
lsr44$$EView_record_in_ScienceDirect_(Access_to_full_text_may_be_restricted)
tmp01ScienceDirect Journals (Elsevier)
tmp02
0--K
1.FO
21P~
3457
4AAEDT
5AAKOC
6ACDAQ
7ADALY
8ADPAM
9AEVXI
10AFKWA
11AFTJW
12AFXIZ
13AGHFR
14AIKHN
15AITUG
16AJUYK
17ALXNB
18BELOY
19BNPGV
20FDB
21FGOYB
22GBLVA
23KOM
24OC.
25ON0
26R2-
27SEL
28SSH
29SSZ
30Z5R
orcidid0000-0002-4297-5346
startdate20180401
enddate20180431
lsr40Pancreatology, April 2018, Vol.18 (3), pp.231-237
doi10.1016/j.pan.2018.02.014
citationpf 231 pt 237 vol 18 issue 3
lsr30VSR-Enriched:[galeid, pqid]
sort
titleDiverse effects of interleukin-22 on pancreatic diseases
authorXuan, Xiuyun ; Tian, Zhiqiang ; Zhang, Mengjie ; Zhou, Jian ; Gao, Weiwu ; Zhang, Yi ; Zhang, Yue ; Lei, Bo ; Ni, Bing ; Wu, Yuzhang ; Fan, Weiping
creationdate20180400
lso0120180400
facets
frbrgroupid6187788121374170371
frbrtype5
newrecords20190904
languageeng
topic
0Pancreatic Cancer
1Interleukin-22
2Cytokine
3Signal Transducer
4Anatomy & Physiology
collectionScienceDirect (Elsevier)
prefilterarticles
rsrctypearticles
creatorcontrib
0Xuan, Xiuyun
1Tian, Zhiqiang
2Zhang, Mengjie
3Zhou, Jian
4Gao, Weiwu
5Zhang, Yi
6Zhang, Yue
7Lei, Bo
8Ni, Bing
9Wu, Yuzhang
10Fan, Weiping
jtitlePancreatology
creationdate2018
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
orcidid0000-0002-4297-5346
aulast
0Xuan
1Tian
2Zhang
3Zhou
4Gao
5Lei
6Ni
7Wu
8Fan
aufirst
0Xiuyun
1Zhiqiang
2Mengjie
3Jian
4Weiwu
5Yi
6Yue
7Bo
8Bing
9Yuzhang
10Weiping
auinitX
auinit1X
au
0Xuan, Xiuyun
1Tian, Zhiqiang
2Zhang, Mengjie
3Zhou, Jian
4Gao, Weiwu
5Zhang, Yi
6Zhang, Yue
7Lei, Bo
8Ni, Bing
9Wu, Yuzhang
10Fan, Weiping
atitleDiverse effects of interleukin-22 on pancreatic diseases
jtitlePancreatology
risdate201804
volume18
issue3
spage231
epage237
pages231-237
issn1424-3903
eissn1424-3911
formatjournal
genrearticle
ristypeJOUR
abstract

Interleukin-22 (IL-22) is involved in the development of lymphocytes and serves as a rapid and early source of the effector cytokines that are released in response to pathogen-induced changes in the microenvironment. Recent research has implicated IL-22 as a potential contributing factor to the spectrum of inflammation-related pancreatic diseases, particularly pancreatitis, fibrosis, carcinoma and diabetes. In this review, we summarize the current knowledge on the roles of IL-22 in the various pancreatic pathogenesis, providing insights into the underlying cellular and signaling mechanisms that will help guide future research into promising interventional targets with therapeutic potential.

pubElsevier B.V
doi10.1016/j.pan.2018.02.014
lad01Pancreatology
date2018-04